Abstract
Background: The coronavirus disease 2019 (COVID-19) had become a health care event endangering humans globally. It takes up a large number of healthcare resources. We studied the impact of COVID-19 on patients with ovarian cancer by comprehensively analyzing their admissions before and after the epidemic, and made reasonable suggestions to improve their current situation.Methods: We randomly divided the enrolled patients into three groups, PreCOVID-19 Group (PCG) (2019.8.20–2020.1.20), COVID-19 Group (CG) (2020.1.21–2020.6.14), and Secondary Outbreak COVID-19 Group (SOCG) (2020.6.15–2020.10.10). One-way ANOVA and chi-square test were used for analysis.Results: The number of patients from other provinces decreased significantly (p < 0.05). The total hospital stay during the epidemic was substantially more extended (p < 0.05). Before the epidemic, our department performed more open surgery while during the epidemic outbreak, we tended to choose laparoscopy (p < 0.01). We took a longer surgery time (P < 0.05). Patients had significantly less post-operative fever during the epidemic (p < 0.001).Conclusion: During the COVID-19 epidemic, no patient was infected with COVID-19, and no patient experienced severe post-operative complications. We recommend maintaining the admissions of patients with ovarian cancer during the epidemic following the rules: 1. The outpatients must complete a nucleic acid test and chest CT in the outpatient clinic; 2. Maintain full daily disinfection of the ward and insist that health care workers disinfect their hands after contact with patients; 3. Increase the use of minimally invasive procedures, including laparoscopy and robotics; 4. Disinfect the ward twice a day with UV light and sodium hypochlorite disinfectant; 5. Patients need to undergo at least three nucleic acid tests before entering the operating room.
Highlights
In December 2019, patients with novel coronavirus infection (COVID-19) appeared in Wuhan, and COVID-19 spread across the country
The first confirmed case of COVID-19 was announced in Beijing on January 20, 2020, after which the hospital began to implement strict management on outpatients and inpatients
49 patients were enrolled in the pre-COVID-19 group (PCG) group, 44 patients were enrolled in the COVID-19 group (CG) group, while 35 patients were enrolled in the secondary outbreak COVID-19 group (SOCG) group
Summary
In December 2019, patients with novel coronavirus infection (COVID-19) appeared in Wuhan, and COVID-19 spread across the country. After June 14, 2020, surgeries can be scheduled if patients have negative results from the nucleic acid screening and chest CT tests. This measure was only extended for 1 week. With the Beijing Municipal Government reducing the response level to the third level again, our hospital began implementing the normalized epidemic management measures. Inpatients needed to complete a nucleic acid screening and chest CT examination in the outpatient clinic; if both resulted to negative, and the doctor scheduled the surgery; 3. The coronavirus disease 2019 (COVID-19) had become a health care event endangering humans globally It takes up a large number of healthcare resources. We studied the impact of COVID-19 on patients with ovarian cancer by comprehensively analyzing their admissions before and after the epidemic, and made reasonable suggestions to improve their current situation
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
